🔴 Gossamer Bio is trading 18% down in pre-market — No clear company-specific catalyst identified

Gossamer Bio is trading 18% down at $0.15, with no clear company-specific catalyst emerging for September 9, 2026.

• Scheduled to present at the Cantor Global Healthcare Conference at 10:55 a.m. ET.
• The announcement was issued September 4 and does not explain the decline.
• Broader sentiment is modestly risk-off, with major U.S. indices lower, but the move is substantially larger than the market pullback.